NCT01816490View on ClinicalTrials.gov

THISTLE - The HIV-HCV Silibinin Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

December 31, 2014

Conditions
HIVHepatitis C
Interventions
DRUG

Intravenous Silibinin (iSIL)

Trial Locations (1)

8091

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT01816490 - THISTLE - The HIV-HCV Silibinin Trial | Biotech Hunter | Biotech Hunter